08:30
#198 Desmopressin orally disintegrating tablet effectively reduces symptoms of nocturia and prolongs undisturbed sleep in patients with nocturia: results of a randomized placebo-controlled study Award for Innovative Research Presented on Nocturnal Voiding ProblemsSponsored by Ferring International
Presenter: Jeffrey Weiss
Weiss J1, Zinner N2, Daneshgari F3, Klein B4, Nørgaard J P4, Ancoli-Israel S51. SUNY Downstate Medical School, 2. UCLA (Geffin) School of Medicine, 3. Case Western Reserve University, 4. Ferring International Pharmascience Center, 5. University of California
08:45
#199 The Effect of Ovariectomy on Bladder Function and Myosin Isoform expression in Female Rabbits with Partial Bladder Outlet Obstruction Best Non-Clinical Abstract
Presenter: Gina Northington
Northington G1, John M1, Chang S1, Alanzi J1, Wein A1, Chacko S11. University of Pennsylvania
09:00
#200 A randomised controlled trial of conservative treatment (pelvic floor muscle training and bladder training) for urinary incontinence in men after prostate surgery (MAPS). Best Clinical Abstract
Presenter: Cathryn Glazener
Glazener C1, Boachie C1, Buckley B2, Cochran C1, Dorey G3, Grant A1, Hagen S4, Kilonzo M1, Moore K5, N'Dow J1, Ramsay C1, Vale L11. University of Aberdeen, 2. Bladder and Bowel Foundation, 3. University of the West of England, 4. Glasgow Caledonian University, 5. University of Alberta
09:15
#201 Changes in bladder contractility after transurethral resection of the prostate
Presenter: Sandra de Zeeuw
de Zeeuw S1, Groen J1, Boevé E R2, van Mastrigt R11. Sector Furore, Department of Urology, Room Ee1630, Erasmus MC, Rotterdam, the Netherlands, 2. Department of Urology, St. Franciscus Gasthuis, Rotterdam, the Netherlands
09:30
#202 Differences in the actions of the M3-antagonist tolterodine and the beta 3 adrenoceptor agonist mirabegron on non-voiding activity in rats with partial outflow obstruction
Presenter: James Gillespie
Gillespie J1, Guilloteau V2, Korstanje C3, Lluel P2, Palea S21. Newcastle University, Uro-physiology Research group, The Dental and Medical School, Newcastle upon Tyne, NE2 4HH England, 2. UROsphere, Faculty of Pharmaceutical Sciences, 35 Chemin des Maraîchers, 31062 Toulouse Cedex 09, France, 3. Astellas Pharma Europe B.V. Elisabethhof 1 2553 EW Leiderdorp The Netherlands
09:45
#203 Effects of a new phosphodiesterase 5 inhibitor, mirodenafil, on the female rat bladder in a partial bladder outlet obstruction model: Physiological and immunohistochemical aspects
Presenter: Jung Yoon Kang
Kang J Y1, Kim H S1, Kim E K2, Kim K M31. Eulji medical center, Department of Urology, 2. Eulji medical center, Department of pathology, 3. Seoul National University, School of Medicine, Department of urology